Mergers and acquisitions in the broader economy are on the rise. After a period of relative quiet, the average M&A deal size grew to $544 million — its highest level in five years — signaling renewed ...

In an M&A deal, make sure to engage seasoned advisors and technology solutions and adopt a disciplined timeline. When you embark on a transaction to sell your business, you’ll find that the world of ...

Abivax delivered outstanding phase 3 results for obefazimod in ulcerative colitis, with a 16.4% placebo-adjusted clinical remission rate. ABVX's safety profile is superior to JAK inhibitors and S1Ps, ...

Johnson & Johnson’s $14.6 billion buyout of Intra-Cellular Therapies in the first month of 2025 suggested it would be a big year for high-priced transactions in the biopharma industry. But it was a ...

Target Corporation has rebounded 35% from distressed levels but is no longer a deep value play. Recent financials were mixed: sales declined, but digital and select categories showed resilience amid ...